CELU Celularity Inc. - Class A Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$0.90
Price · May 22, 2026
Fundamentals as of Apr 30, 2026
52W Range
$1–$4
5% of range
Analyst Rating
BUY
7 analysts
Price Target
—
P/E (TTM)
-0.3
ROE
288.6%
Net Profit Margin
-345.4%

CELU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.90
Market Cap
$32M
P/E (TTM)
-0.3
EPS (TTM)
$-3.59
Revenue (TTM)
$27M
Div Yield
—
ROE
288.6%
Debt/Equity
—
52W Range
$1 – $4

CELU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $27M
2-point trend, -51.0%
2024-12-31 → 2025-12-31
EPS $-3.59
2-point trend, -36.0%
2024-12-31 → 2025-12-31
Free Cash Flow —
Margins -345.4%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
CELU
Peer Median
P/E (TTM)
-0.3
—
P/S (TTM)
1.2
16.8
P/B
-0.8
3.5

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
CELU
Peer Median
Operating Margin
-230.9%
—
Net Profit Margin
-345.4%
-270.9%
ROA
-76.4%
-65.0%
ROE
288.6%
-97.9%
ROIC
161.1%
—

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
CELU
Peer Median
Current Ratio
0.2
2.1
Quick Ratio
0.1
—

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
CELU
Peer Median
Revenue YoY
2-point trend, -51.0%
-51.0%
—

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
CELU
Peer Median
EPS (Diluted)
2-point trend, -36.0%
$-3.59
—

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
CELU
Peer Median

CELU Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 7 analysts
  • Strong Buy 2 28.6%
  • Buy 4 57.1%
  • Hold 1 14.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.74%
Next Report
Jun 08, 2026
Period EPS Actual EPS Est Surprise
Dec. 31, 2025 $-0.85 $-1.53 0.68%
Sept. 30, 2025 $-0.88 $-1.53 0.65%
June 30, 2025 $-1.02 $-0.77 -0.26%
March 31, 2025 $-0.84 $-0.77 -0.07%
Sept. 30, 2023 $-5.00 $-0.31 -4.7%

Peer Comparison Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
CELU $32M -0.3 -51.0% -345.4% 288.6% —
DYAI — -4.1 -11.6% — — —
AIXC $12M -0.3 — — -110.8% —
CLRB — -0.4 — — — —
ALLR $17M -0.0 — -3509.7% -102.1% —
JSPR — -0.5 — — — —
VTGN — -1.5 -54.3% -10579.8% -67.9% —
SNSE $13M -0.6 — — -91.9% —

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 14
Annual Income Statement data for CELU
Metric Trend 20252024
Revenue 2-point trend, -51.0% $27M $54M
Cost of Revenue 2-point trend, +33.9% $20M $15M
R&D Expense 2-point trend, -13.6% $15M $17M
SG&A Expense 2-point trend, -12.6% $51M $59M
Operating Income 2-point trend, -59.8% $-61M $-38M
Other Non-op · $2M
Pretax Income 2-point trend, -58.4% $-92M $-58M
Income Tax $3.0K ·
Net Income 2-point trend, -58.4% $-92M $-58M
EPS (Basic) 2-point trend, -36.0% $-3.59 $-2.64
EPS (Diluted) 2-point trend, -36.0% $-3.59 $-2.64
Shares (Basic) 2-point trend, +16.9% 25,598,586 21,890,518
Shares (Diluted) 2-point trend, +16.9% 25,598,586 21,890,518
EBITDA $-54M ·
Balance Sheet 25
Annual Balance Sheet data for CELU
Metric Trend 20252024
Cash & Equivalents 2-point trend, +736.7% $6M $738.0K
Inventory 2-point trend, -89.4% $571.0K $5M
Prepaid Expense 2-point trend, +7.4% $920.0K $857.0K
Current Assets 2-point trend, -40.1% $12M $21M
PP&E (Net) 2-point trend, -9.4% $56M $62M
PP&E (Gross) Flat — no change across 2 periods $94M $94M
Accum. Depreciation 2-point trend, +17.7% $39M $33M
Goodwill Flat — no change across 2 periods $7M $7M
Intangibles 2-point trend, -16.1% $8M $9M
Other Non-current Assets 2-point trend, -8.5% $247.0K $270.0K
Total Assets 2-point trend, -19.1% $107M $133M
Accounts Payable 2-point trend, +13.4% $26M $23M
Accrued Liabilities 2-point trend, +59.0% $33M $20M
Current Liabilities 2-point trend, +50.4% $81M $54M
Capital Leases 2-point trend, +1.3% $27M $27M
Deferred Tax 2-point trend, +33.3% $12.0K $9.0K
Other Non-current Liabilities 2-point trend, -5.0% $266.0K $280.0K
Total Liabilities 2-point trend, +17.4% $145M $124M
Common Stock 2-point trend, +50.0% $3.0K $2.0K
Paid-in Capital 2-point trend, +4.9% $953M $909M
Retained Earnings 2-point trend, -10.2% $-991M $-900M
AOCI · $-5.0K
Stockholders' Equity 2-point trend, -530.7% $-38M $9M
Liabilities + Equity 2-point trend, -19.1% $107M $133M
Shares Outstanding 2-point trend, +27.9% 28,837,787 22,546,671
Cash Flow 11
Annual Cash Flow data for CELU
Metric Trend 20252024
D&A 2-point trend, -7.9% $7M $8M
Amort. of Intangibles 2-point trend, -14.8% $1M $2M
Other Non-cash $71M ·
Operating Cash Flow 2-point trend, -107.1% $-13M $-6M
CapEx · $161.0K
Investing Cash Flow · $514.0K
Stock Issued $1M ·
Net Stock Activity $1M ·
Financing Cash Flow 2-point trend, +178.3% $19M $7M
Net Change in Cash 2-point trend, +562.8% $5M $814.0K
Taxes Paid $52.0K ·
Profitability 7
Annual Profitability data for CELU
Metric Trend 20252024
Operating Margin -230.9% ·
Net Margin -345.4% ·
Pretax Margin -345.4% ·
EBITDA Margin -203.4% ·
ROA -76.4% ·
ROE 288.6% ·
ROIC 161.1% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for CELU
Metric Trend 20252024
Current Ratio 0.2 ·
Quick Ratio 0.1 ·
Efficiency 2
Annual Efficiency data for CELU
Metric Trend 20252024
Asset Turnover 0.2 ·
Inventory Turnover 6.7 ·
Per Share 5
Annual Per Share data for CELU
Metric Trend 20252024
Book Value / Share $-1.32 ·
Revenue / Share $1.04 ·
Cash Flow / Share $-0.52 ·
Cash / Share $0.21 ·
EPS (TTM) $-3.59 ·
Growth Rates 1
Annual Growth Rates data for CELU
Metric Trend 20252024
Revenue YoY -51.0% ·
Valuation (TTM) 8
Annual Valuation (TTM) data for CELU
Metric Trend 20252024
Revenue TTM $27M ·
Net Income TTM $-92M ·
Market Cap $32M ·
P/E -0.3 ·
P/S 1.2 ·
P/B -0.8 ·
P / Cash Flow -2.4 ·
Earnings Yield -323.4% ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-31
Revenue $27M$54M
Operating Margin % -230.9%—
Net Income $-92M$-58M
Diluted EPS $-3.59$-2.64
Balance Sheet
2025-12-312024-12-31
Current Ratio 0.2—
Quick Ratio 0.1—

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.